Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Treatment Type

  2.3.2 Market Size By Diagnostic Method

  2.3.3 Market Size By Disease Type

 2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Treatment Utilization & Therapy Adoption Analysis

  4.1.1 Overview

  4.1.2 Treatment Adoption Analysis By Treatment Type, 2022–2035

      4.1.3 Therapy Benchmarking By Leading Pharmaceutical Companies, 2024

 4.2 Regulatory & Clinical Guidelines Landscape

  4.2.1 Overview

  4.2.2 Autoimmune Neurology Regulatory & Clinical Guideline Trends By Key Countries

      4.2.3 Regulatory Outlook By Treatment & Diagnostic Method

 4.3 Autoimmune Encephalitis Diagnostic Infrastructure Analysis

  4.3.1 Overview

  4.3.2 Autoimmune Encephalitis Testing Capacity, By Country

5. Autoimmune Encephalitis Treatment & Diagnostics Market Segmental Analysis & Forecast, By Treatment Type, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 First-line Immunotherapy (Steroids, IVIG & Plasma Exchange)

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 B-cell Targeted Therapy (Rituximab)

 5.4 Immunosuppressant

 5.5 Emerging Biologics & FcRn/Cytokine Therapies

 5.6 Others

6. Autoimmune Encephalitis Treatment & Diagnostics Market Segmental Analysis & Forecast, By Diagnostic Method, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Autoantibody Testing (Serum & CSF)

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 MRI & Neuroimaging

 6.4 EEG

 6.5 CSF Analysis & Biomarkers

 6.6 Others 

7. Autoimmune Encephalitis Treatment & Diagnostics Market Segmental Analysis & Forecast, By Disease Type, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Anti-NMDA Receptor Encephalitis

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 LGI1 Encephalitis

 7.4 CASPR2 Encephalitis

 7.5 Paraneoplastic Autoimmune Encephalitis

 7.6 Others

8. Autoimmune Encephalitis Treatment & Diagnostics Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Neurology Specialty Centers

 8.4 Academic & Research Institutes

 8.5 Diagnostic Laboratories

 8.6 Others

9. Autoimmune Encephalitis Treatment & Diagnostics Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Treatment Type, 2022–2035

 9.2.3 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Diagnostic Method, 2022–2035

 9.2.4 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Disease Type, 2022–2035

 9.2.5 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By End User, 2022–2035

 9.2.6 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Treatment Type, 2022–2035

 9.3.3 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Diagnostic Method, 2022–2035

 9.3.4 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Disease Type, 2022–2035

 9.3.5 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By End User, 2022–2035

 9.3.6 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Treatment Type, 2022–2035

 9.4.3 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Diagnostic Method, 2022–2035

 9.4.4 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Disease Type, 2022–2035

 9.4.5 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By End User, 2022–2035

 9.4.6 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Treatment Type, 2022–2035

 9.5.3 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Diagnostic Method, 2022–2035

 9.5.4 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Disease Type, 2022–2035

 9.5.5 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By End User, 2022–2035

 9.5.6 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Treatment Type, 2022–2035

 9.6.3 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Diagnostic Method, 2022–2035

 9.6.4 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Disease Type, 2022–2035

 9.6.5 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By End User, 2022–2035

 9.6.6 Autoimmune Encephalitis Treatment & Diagnostics Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Treatment Type/Service & Diagnostic Method Benchmarking

  10.4.1 Treatment Type/Service Specifications & Features By Key Players

  10.4.2 Treatment Type/Service Heatmap By Key Players

  10.4.3 Diagnostic Method Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

  10.6.1 F. Hoffmann-La Roche Ltd.

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Treatment Type/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

  10.6.2 UCB S.A.

10.6.3 Novartis AG

10.6.4 Sanofi S.A.

10.6.5 Pfizer Inc.

10.6.6 Bristol Myers Squibb

10.6.7 AstraZeneca PLC

10.6.8 Amgen Inc.

10.6.9 CSL Behring

10.6.10 Grifols S.A.

10.6.11 Takeda Pharmaceutical Company Limited

10.6.12 Biogen Inc.

10.6.13 argenx SE

10.6.14 Arialys Therapeutics

10.6.15 Evergreen Therapeutics Inc.

10.6.16 Siemens Healthineers AG

10.6.17 Thermo Fisher Scientific Inc.

10.6.18 Mayo Clinic Laboratories

10.6.19 Quest Diagnostics Incorporated

10.6.20 Euroimmun AG

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures